Skip to main content
Premium Trial:

Request an Annual Quote

SpeeDx, Diagen Sign Distribution Agreement for Scandinavia

NEW YORK (GenomeWeb) – SpeeDx has announced a distribution agreement with Diagen, a Scandinavian clinical laboratory supplier.

The agreement will open crucial sales channels in Denmark, Sweden, and Norway for SpeeDx's PlexPCR and ResistancePlus real-time PCR product lines.

Using SpeeDx's technology, the PlexPCR range will enable Diagen customers to receive diagnostic information on STIs and other infectious diseases from a single test. The agreement will also provide Diagen customers access to SpeeDx's ResistancePlus MG assay, which tests for the Mycoplasma genitalium STI. SpeeDx's assay is the first CE-IVD test to simultaneously detect M. genitalium and genetic markers for azithromycin resistance, as recommended by new European guidelines on M. genitalium resistance screening in the management of  non-gonococcal urethritis.     

SpeeDx announced yesterday that the New South Wales Medical Devices Fund has granted the company A$2.5 million (US$2 million) for the continued rollout of the ResistancePlus MG test.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.